Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Cervical Cancer

Clinical trial condition

Recurrent Cervical Cancer

Explore clinical trials studying Recurrent Cervical Cancer. Study availability and eligibility vary by location and protocol.

24 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Cervical Cancer trial results

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix

NCT00031993

Conditions: Cervical Squamous Cell Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

NCT00335998

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +42 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details